Aptevo Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Aptevo Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Aptevo Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Aptevo Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Aptevo Therapeutics Clinical Trials
Determine Aptevo Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Aptevo Therapeutics Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML | GDCT0427586 | APVO-436 | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) | Phase I | Withdrawn | Aptevo Therapeutics Inc |
| Study to Evaluate APVO210 in Healthy Subjects, Patients with Psoriasis, and Patients with Ulcerative Colitis | GDCT0330584 | APVO-210 | Gastrointestinal; Immunology | Plaque Psoriasis (Psoriasis Vulgaris); Psoriasis; Ulcerative Colitis | Phase I | Terminated | Aptevo Therapeutics Inc |
| A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Anti-tumor Activity of ALG.APV-527 for the Treatment of Several Different Types of Solid Tumors That Express the 5T4 Tumor Antigen. | GDCT0311801 | ALG.APV-527 | Oncology | Bladder Cancer; Breast Cancer; Cervical Cancer; Colorectal Cancer; Endometrial Cancer; Gastric Cancer; Gastroesophageal (GE) Junction Carcinomas; Head And Neck Cancer; Head And Neck Cancer Squamous Cell Carcinoma; Kidney Cancer (Renal Cell Cancer); Malignant Pleural Mesothelioma; Non-Small Cell Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Solid Tumor; Throat Cancer; Transitional Cell Carcinoma (Urothelial Cell Carcinoma) | Phase I | Ongoing, recruiting | Aptevo Therapeutics Inc |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer